Injectable hydrogels for ophthalmic applications
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The demand for effective eye therapies is driving the development of injectable hydrogels as new medical devices for controlled delivery and filling purposes. This article introduces the properties of injectable hydrogels and summarizes their versatile application in the treatment of ophthalmic diseases, including age-related macular degeneration, cataracts, diabetic retinopathy, glaucoma, and intraocular cancers. A number of injectable hydrogels are approved by FDA as surgery sealants, tissue adhesives, and are now being investigated as a vitreous humor substitute. Research on hydrogels for drug, factor, nanoparticle, and stem cell delivery is still under pre-clinical investigation or in clinical trials. Although substantial progress has been achieved using injectable hydrogels, some challenging issues must still be overcome before they can be effectively used in medical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Hydrogels for biomedical applications
Hoffman, A. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00239-3 · Cited by 4,864
Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology
Peppas, N. A., Hilt, J. Z., Khademhosseini, A., & Langer, R. (2006) · Advanced Materials · doi:10.1002/adma.200501612 · Cited by 4,109
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
(2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102673 · Cited by 2,669
Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.477 · Cited by 2,616
25th Anniversary Article: Rational Design and Applications of Hydrogels in Regenerative Medicine
Annabi, N., Tamayol, A., Uquillas, J. A., Akbari, M., Bertassoni, L. E., Cha, C., Camci‐Unal, G., Dokmeci, M. R., Peppas, N. A., & Khademhosseini, A. (2014) · Advanced Materials · doi:10.1002/adma.201303233 · Cited by 1,409
Age-related macular degeneration
Jager, R. D., Mieler, W. F., & Miller, J. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801537 · Cited by 1,379
Bennett, J., Wellman, J., Marshall, K. A., McCague, S., Ashtari, M., DiStefano-Pappas, J., Elci, O. U., Chung, D. C., Sun, J., Wright, J. F., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30371-3 · Cited by 461
Saaddine, J. B. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.12.1740 · Cited by 377 · cited 2×
“These diagnoses lead to 26 million doctor visits annually in the US [1, 2, 7, 8] and more in other parts of the world.”
BackgroundIncorporation of heparin into biomaterials
Sakiyama-Elbert, S. E. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.08.045 · Cited by 222 · cited 3×
“2 Drug Delivery—The fibrin with a bi-domain peptide incorporated has a drug release profile which is controlled through reversible binding, and the system can form a gel in situ [88].”
Background
Cited by
Mandal, A., Clegg, J. R., Anselmo, A. C., & Mitragotri, S. (2020) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10158 · Cited by 491
Nanocellulose: Recent Fundamental Advances and Emerging Biological and Biomimicking Applications
Heise, K., Kontturi, E., Allahverdiyeva, Y., Tammelin, T., Linder, M. B., Nonappa, & Ikkala, O. (2021) · Advanced Materials · doi:10.1002/adma.202004349 · Cited by 425
Advances in injectable self-healing biomedical hydrogels
Tu, Y., Chen, N., Li, C., Liu, H., Zhu, R., Chen, S., Xiao, Q., Liu, J., Ramakrishna, S., & He, L. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.03.057 · Cited by 351
Recent advances of injectable hydrogels for drug delivery and tissue engineering applications
Sun, Y., Nan, D., Jin, H., & Qu, X. (2020) · Polymer Testing · doi:10.1016/j.polymertesting.2019.106283 · Cited by 227
An insight on ophthalmic drug delivery systems: focus on polymeric biomaterials-based carriers
Shafiq, M., Rafique, M., Cui, Y., Pan, L., Do, C.-W., & Ho, E. A. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.08.041 · Cited by 67
Metadata
- Authors
- Wang, K., & Han, Z.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 268
- Pages
- 212-224
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2766087240
- Cited by
- 155
- References
- 11
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Injectable hydrogels for ophthalmic applications. https://app.cochat.ai/papers/10.1016/j.jconrel.2017.10.031
- The paper
- Wang, K., & Han, Z. (2017). Injectable hydrogels for ophthalmic applications. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2017.10.031
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.